VIEW
2 known investors
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.
Founders & leadership
AS
Ajay ShahCo-founder & CEO
HT
Henry TseCo-founder & Chief Technology Officer
Investors · 2
In the news
- Forward Financing $525 Million: VFN + ABS Deal Explainedfunderintel.com · 2026